Understanding anxiety disorders, panic and fear

Anxiety is a normal human alarm system. An anxiety disorder is different: fear, worry or avoidance becomes persistent, difficult to control and significant enough to restrict everyday life.

This guide explains what anxiety is, how the main disorders differ, what else can look like anxiety, and which treatments are supported by current evidence and UK guidance.

Anxiety at a glance

Anxiety disorders are the most common mental disorders worldwide. The World Health Organization estimated that 359 million people were living with an anxiety disorder in 2021, around 4.4% of the global population. Effective treatments exist, yet only about one in four people with an anxiety disorder receive treatment. [1]

_{Normal anxiety or an anxiety disorder?}

_{Normal anxiety is usually proportionate to a challenge and settles when the challenge passes. An anxiety disorder is more likely when fear or worry is excessive, persists for months, feels hard to control, produces marked physical or cognitive symptoms, drives avoidance or reassurance-seeking, and interferes with work, study, relationships, sleep, travel or self-care.}

1. What anxiety is — and what keeps it going

Anxiety is a survival system designed to detect threat and prepare the body to respond. It combines rapid brain-based threat detection, autonomic arousal, hormonal signalling, attention to possible danger and learning from previous experience. This system is useful when danger is real. Problems arise when the alarm is triggered too easily, remains switched on, or becomes linked to situations that are safe but feel threatening.

The anxiety cycle

1 Trigger

A thought, memory, sensation, place, social situation, uncertainty or real-life problem is noticed.

2 Threat interpretation

The mind predicts danger: “something bad will happen”, “I will lose control”, “they will judge me”.

3 Body alarm

Adrenaline and sympathetic arousal increase heart rate, breathing, sweating, muscle tension, nausea and vigilance.

4 Safety behaviour

Avoidance, escape, checking, reassurance, over-preparation, substance use or repeated internet searching brings short-term relief.

5 Learning

Relief reinforces the safety behaviour, so the brain never fully learns that the feared situation can be tolerated or is safer than expected.

This is why avoidance is such a powerful maintaining factor. It works immediately, which makes it tempting, but repeated avoidance can shrink a person’s life and preserve the fear. Evidence-based CBT and exposure therapies deliberately reverse this learning cycle.

Why some people develop anxiety disorders

There is no single cause. Risk develops through a mixture of inherited vulnerability, temperament, learning, life events, chronic stress, physical health, sleep, social circumstances and neurobiology. Family history matters, but genes are not destiny. Childhood adversity and trauma can increase risk, while supportive relationships, predictable routines, good sleep, physical activity and effective coping can be protective. [1]

· Genetic and temperamental factors, including behavioural inhibition and greater sensitivity to threat or uncertainty.

· Learning and conditioning: frightening experiences, modelling of fear, repeated avoidance and reassurance can strengthen threat associations.

· Chronic stress, bullying, discrimination, caregiving strain, financial insecurity, illness, bereavement or relationship disruption.

· Sleep disruption, pain, hormonal changes and physical illness, which can increase arousal and reduce emotional resilience.

· Substances and medicines that increase physiological arousal or produce withdrawal symptoms.

Neurobiology without oversimplification

Anxiety is not explained by a single “chemical imbalance”. Research implicates interacting fear, salience and regulation networks involving the amygdala, insula, prefrontal cortex, hippocampus and brainstem, alongside serotonin, noradrenaline, GABA and other signalling systems. The useful clinical model is a network-and-learning model, not a one-neurotransmitter story.

2. Symptoms: body, thoughts, emotions and behaviour

Anxiety can look surprisingly physical. Some people first present because of palpitations, dizziness, gastrointestinal symptoms, breathlessness, headaches or poor sleep rather than because they identify themselves as anxious. NHS guidance emphasises that anxiety can affect the body, thoughts and behaviour. [4]

Domain	Common manifestations
Body	Palpitations or pounding heart; sweating; shaking; shortness of breath; chest tightness; dry mouth; dizziness; tingling; nausea; abdominal discomfort; diarrhoea; muscle tension; headaches; urinary frequency; feeling hot or cold.
Thoughts	Persistent worry; catastrophic predictions; difficulty concentrating; intrusive “what if?” thoughts; fear of losing control; hypervigilance; scanning the body; indecision; rumination after events.
Emotions	Fear; dread; irritability; tension; feeling on edge; shame; embarrassment; frustration; emotional exhaustion.
Behaviour	Avoiding places or people; cancelling plans; leaving early; repeated checking; reassurance-seeking; over-preparing; procrastinating; using alcohol or drugs to cope; restricting travel or daily activities.
	Panic attacks A panic attack is a sudden surge of intense fear or discomfort with rapid physical symptoms. Attacks often peak within minutes and commonly settle within 5–20 minutes, although the after-effects can last longer. A panic attack can occur in panic disorder, other anxiety disorders, PTSD, depression, substance states or without a psychiatric disorder. New or atypical chest pain, collapse, severe breathlessness or neurological symptoms should not automatically be assumed to be panic. [4]

3. The main anxiety disorders

Modern diagnostic systems group several conditions under anxiety disorders. The core theme is excessive fear or anxiety, but the object of fear and the pattern of avoidance differ.

Generalised anxiety disorder (GAD)

Persistent, hard-to-control worry across several areas of life, commonly accompanied by restlessness, fatigue, muscle tension, irritability, sleep disturbance and poor concentration. The worry is broad rather than limited to one trigger.

Panic disorder

Recurrent unexpected panic attacks plus ongoing concern about further attacks or their consequences, often leading to behavioural change. Panic disorder is not simply “being anxious a lot”.

Agoraphobia

Marked fear or avoidance of situations where escape or help may feel difficult if panic-like symptoms occur—for example public transport, crowds, queues, open or enclosed spaces, or being outside home alone.

Persistent fear of scrutiny, embarrassment or negative evaluation in social or performance situations. Anticipatory anxiety and prolonged post-event rumination are common. Disorder-specific individual CBT is the NICE first-line psychological treatment for adults. [3]

Specific phobia

Intense fear of a particular object or situation—such as animals, heights, blood/injections, flying or enclosed spaces—leading to immediate anxiety and avoidance. Exposure-based treatment is usually central.

Separation anxiety disorder

Developmentally inappropriate and excessive fear about separation from important attachment figures. Although associated with childhood, it can persist into or begin in adulthood.

Selective mutism

Consistent inability to speak in specific social settings despite speaking in others. It is usually identified in childhood and strongly overlaps with social anxiety; treatment is primarily behavioural and environmental, often involving family and school.

Important classification correction for 2026

Obsessive-compulsive disorder (OCD) and post-traumatic stress disorder (PTSD) are not classified as anxiety disorders in DSM-5/DSM-5-TR. They sit in separate “obsessive-compulsive and related” and “trauma- and stressor-related” families. Both can involve intense anxiety and are treated within NHS Talking Therapies, so cross-linking them from an anxiety page remains useful—but they should not be presented as subtypes of anxiety disorder.

Health anxiety

Health anxiety is a clinically important pattern of persistent fear of illness, often involving body checking, repeated reassurance, repeated medical or internet searching, or avoidance of health information. In UK services it is commonly treated with CBT and is included within NHS Talking Therapies pathways. [5]

Good assessment does not stop at “anxious”. The same symptoms may arise from another psychiatric condition, a physical disorder, a medicine or a substance. Sometimes more than one explanation is true at the same time.

Depression

Anxiety and depression frequently coexist. Low mood may generate worry; chronic anxiety may lead to demoralisation. Treatment sequencing should reflect which syndrome is primary, most impairing and most urgent.

OCD

Intrusive obsessions and compulsions can be mistaken for general worry. The presence of rituals, mental neutralising or repeated checking aimed at reducing obsessional distress points toward OCD.

PTSD / trauma

Hypervigilance, avoidance and panic can follow trauma. PTSD additionally involves trauma-linked re-experiencing, negative alterations in mood/cognition and persistent threat response.

ADHD / autism

Executive overload, sensory stress, uncertainty, social performance demands, rejection experiences and chronic compensatory effort can generate secondary anxiety. True anxiety disorders can also coexist.

Bipolar / psychosis

Agitation, insomnia, racing thoughts, suspiciousness or unusual experiences can be misread as anxiety. Mood elevation, psychotic symptoms or major behavioural change need a broader assessment.

Physical illness

Thyroid disease, arrhythmia, asthma, anaemia, vestibular disorders, hypoglycaemia and other conditions may mimic or amplify anxiety symptoms.

5. Assessment and diagnosis

Diagnosis is clinical. Questionnaires can quantify symptoms and track change, but they do not diagnose an anxiety disorder by themselves. A good assessment identifies the feared outcome, triggers, avoidance, safety behaviours, time course, functional impairment, comorbidity and alternative explanations.

· Clarify onset, duration, frequency, triggers and whether symptoms are episodic or persistent.

· Map avoidance and safety behaviours: what has the person stopped doing, and what do they do to feel safe?

· Assess work, study, relationships, parenting, sleep, driving, travel, finances and self-care.

· Review depression, OCD, PTSD, eating problems, ADHD/autism, substance use, psychosis and bipolar symptoms where relevant.

· Review caffeine, nicotine, alcohol, cannabis, stimulants, recreational drugs, steroids, decongestants and medication withdrawal.

· Consider physical examination or investigations when symptoms, history or risk factors suggest a medical cause.

· Assess self-harm, suicidality, domestic abuse, safeguarding, severe self-neglect and inability to function.

Useful measures

Common measures include the GAD-7 for generalised anxiety symptoms, PHQ-9 for depression, SPIN or LSAS for social anxiety, and disorder-specific panic or phobia scales. Scores are useful for monitoring severity and response, but should be interpreted alongside the clinical picture. NICE specifically recommends validated measures such as SPIN or LSAS when assessing social anxiety. [3]

6. Treatment in 2026

Treatment should match the specific anxiety disorder, severity, impairment, previous treatment, comorbidity and patient preference. UK care is broadly stepped: begin with education and the least intrusive effective option, then move to more intensive psychological treatment, medication or combined care when symptoms are persistent or disabling. [2]

Psychological treatments

Approach	Role
CBT	The best-established psychological treatment across anxiety disorders. Modern meta-analytic evidence continues to support clinically meaningful benefit for GAD, panic disorder, social anxiety and specific phobias. [7,8]
Exposure therapy	A central component for phobias, panic, agoraphobia and social anxiety. Exposure is planned and repeated rather than forced; the goal is new learning, not simply “enduring” fear.
Applied relaxation	An evidence-based option for GAD in NICE stepped care. It trains early detection of anxiety and rapid relaxation skills, but should not become a safety behaviour that prevents exposure learning.
CBT-based guided self-help	Useful for milder GAD/panic presentations and available through NHS Talking Therapies. Guidance and support improve adherence compared with simply handing someone a workbook.
Acceptance-based / third-wave approaches	Acceptance-based CBT and related approaches can help some people with GAD, particularly around intolerance of uncertainty and the struggle with internal experiences. Recent network meta-analysis supports benefit, while conventional CBT remains a core evidence-based choice. [9]
Digital / internet CBT	Internet-delivered CBT now has a substantial evidence base. Guided programmes can widen access and may maintain benefits over longer follow-up, but quality, clinical oversight and suitability vary. [10]

What about mindfulness?

Mindfulness, yoga and breathing practices can be useful for stress regulation and may reduce anxiety symptoms for some people, but they are not interchangeable with disorder-specific treatment. For example, NICE does not recommend mindfulness-based interventions as a routine treatment for social anxiety disorder. Use them as adjuncts where they help, rather than presenting them as universal first-line therapy. [3]

Exercise

Physical activity is a useful adjunct, not a substitute for indicated psychological or medical treatment. A 2026 network meta-analysis of adults with anxiety disorders found evidence of benefit across several exercise approaches, with resistance and mind-body exercise ranking highly, although study quality and certainty vary. Another 2026 review of generalised anxiety symptoms found potential benefit but substantial heterogeneity. The practical message is simple: regular sustainable activity is reasonable to recommend, but there is no single proven “best anxiety workout”. [11,12]

7. Medication: benefits, limitations and withdrawal

Medication can reduce anxiety symptoms and may make psychological work more manageable. It should be chosen according to diagnosis, previous response, side effects, physical health, pregnancy potential, interactions, overdose risk, substance-use history and patient preference. Medication is not evidence that anxiety is “just chemical”; it is one way of altering symptom-generating systems while recovery also depends on learning, behaviour and context.

Medication class	2026 practical perspective
SSRIs	Common first-line medicines for GAD, panic and social anxiety. Examples used in UK practice include sertraline and escitalopram. Early activation—temporary increased anxiety, agitation or sleep disturbance—can occur. Benefit develops over weeks, not hours.
SNRIs	Also evidence-based for some anxiety disorders. Venlafaxine and duloxetine are examples. Discontinuation symptoms can be prominent with some agents, so stopping should generally be gradual and planned.
Pregabalin	NICE allows pregabalin as an option for GAD when SSRIs/SNRIs are not tolerated. In the UK it is a Schedule 3 controlled drug; dependence, misuse, sedation and withdrawal need consideration. [2]
Benzodiazepines	Fast-acting but not routine long-term treatment. NICE advises against benzodiazepines for GAD except short-term during crises and states they should not be prescribed for panic disorder because of poorer long-term outcome. Tolerance, dependence, cognitive effects and withdrawal are key risks. [2]
Beta-blockers	May reduce peripheral symptoms such as tremor or palpitations in selected performance situations, but they do not treat the full cognitive/avoidance pattern of an anxiety disorder and are not routine first-line treatment.
Other / specialist options	Some refractory cases require specialist review and diagnosis-specific alternatives. More medication is not always better; inadequate psychological treatment, ongoing substance use, missed comorbidity or an incorrect formulation should be reconsidered first.
	Do not stop suddenly Antidepressants, benzodiazepines and pregabalin can all produce withdrawal symptoms. Withdrawal may include anxiety, insomnia, dizziness, sensory symptoms, nausea, agitation or rebound symptoms and can be mistaken for relapse. Dose reductions should be individualised and discussed with the prescriber rather than stopped abruptly.

8. Self-management and panic first aid

What tends to help

· Reduce avoidance gradually. Build a graded hierarchy rather than waiting to feel completely calm before doing feared activities.

· Notice safety behaviours. Reassurance, checking, carrying “just in case” items or rehearsing every sentence can keep anxiety going even when they look sensible.

· Keep sleep and wake times reasonably consistent. Sleep deprivation increases threat sensitivity and makes physical anxiety harder to interpret accurately.

· Moderate caffeine and other stimulants, especially if palpitations, tremor or panic are prominent.

· Use regular exercise for general regulation and health, choosing something sustainable rather than a punishing routine.

· Practise slow, comfortable breathing if over-breathing is contributing to dizziness or tingling. Avoid turning breathing into a ritual you believe you must perform to be safe.

· Track progress by what you can do, not only by how anxious you feel. Successful exposure can still feel uncomfortable while the brain is learning.

During a panic attack

Name what is happening: “This is a panic response. It is intense, but it will pass.”
If you are physically safe, try not to flee immediately. Staying long enough for the wave to fall can weaken the fear–escape link.
Slow the breathing rather than taking repeated huge breaths. Over-breathing can increase tingling, dizziness and chest sensations.
Anchor attention externally: notice what you can see, hear and feel around you rather than repeatedly checking your pulse or breathing.
Afterwards, avoid a long post-mortem. Record what you predicted would happen and what actually happened; this is useful exposure learning.

When not to assume “it is only panic”

Seek urgent medical assessment for a first or clearly different episode with concerning chest pain, collapse, severe breathlessness, new neurological symptoms, serious injury, suspected overdose, or another reason to think a physical emergency may be occurring.

Common traps

Endless reassurance

Relief lasts briefly, then doubt returns. The long-term target is increasing tolerance of uncertainty.

Avoiding every trigger

Life becomes smaller and feared situations remain untested. Graded exposure is usually more effective.

Using alcohol to socialise

Short-term calming can be followed by rebound anxiety, poor sleep and increasing reliance.

Compulsive symptom searching

Repeated online checking can intensify health anxiety and increase attention to normal body sensations.

Waiting to feel ready

Confidence often follows action rather than preceding it. Treatment aims to function while some anxiety is present.

Chasing “zero anxiety”

A realistic goal is flexible functioning, reduced impairment and confidence in coping—not the complete removal of normal anxiety.

9. ADHD, autism and anxiety

Anxiety is especially relevant in neurodevelopmental care. Large studies show markedly higher rates of anxiety disorders among adults with ADHD than among adults without ADHD, and a 2026 meta-analysis found substantially higher anxiety symptom scores in adults with ADHD compared with controls. [13]

The overlap is clinically important because anxiety can worsen attention, working memory, sleep and emotional regulation, while ADHD-related disorganisation, time pressure, rejection experiences and repeated performance problems can generate secondary anxiety. In autism, sensory overload, uncertainty, social ambiguity and masking can also present as anxiety or amplify a separate anxiety disorder.

ADHD medication and anxiety

Stimulant medication can occasionally increase jitteriness, palpitations or subjective anxiety, especially with excessive caffeine, sleep deprivation or rapid dose escalation. Equally, effective ADHD treatment can reduce anxiety that was driven by chronic disorganisation, missed deadlines or repeated failures. The relevant question is what happens to the individual’s anxiety pattern during careful titration—not whether stimulants are universally “good” or “bad” for anxiety.

10. Alcohol, caffeine, cannabis and other substances

Substances can both relieve and worsen anxiety. This makes the timeline essential: what is used, how much, how often, what happens during intoxication, and what happens hours or days later?

· Caffeine can worsen palpitations, tremor, insomnia and panic-like sensations, particularly at high doses or when combined with stimulants.

· Alcohol may reduce anxiety briefly but commonly worsens sleep and can produce rebound anxiety; dependence and withdrawal can cause severe anxiety and autonomic symptoms.

· Cannabis can feel calming for some people but can also provoke panic, paranoia, depersonalisation or impaired functioning; higher-THC products may be more problematic.

· Cocaine, amphetamines and other stimulants can produce anxiety, panic, insomnia and suspiciousness, while withdrawal can produce dysphoria and exhaustion.

· Benzodiazepine or pregabalin misuse can create a cycle of short-term relief followed by tolerance, withdrawal and worsening baseline anxiety.

11. Children, pregnancy and later life

Children and young people

Anxiety often begins in childhood or adolescence. Presentation may include school avoidance, stomach aches, irritability, freezing, repeated reassurance, perfectionism, sleep problems or refusal to speak in specific settings. Treatment should involve developmentally appropriate CBT/exposure and, where relevant, parents or school. Medication is not simply a scaled-down version of adult treatment and should follow child and adolescent guidance.

Pregnancy and the postnatal period

Anxiety may begin or worsen during pregnancy or after birth. Treatment decisions should balance the risks of untreated illness against medication risks, previous response and relapse history. Do not abruptly stop established medication solely because of pregnancy; seek timely perinatal or prescribing advice.

Later life

New anxiety in later life deserves careful review for physical illness, medication effects, cognitive change, pain, bereavement, loneliness, sleep disorders and depression. Older adults can still benefit from CBT and other evidence-based treatments; treatment should be adapted for hearing, vision, cognition, mobility and polypharmacy when necessary.

12. What is emerging in 2026

The direction of travel is not toward abandoning established therapy, but toward making effective treatment more accessible, personalised and easier to practise in real-world settings.

Digital CBT and hybrid care

Internet-delivered CBT has moved from novelty to a credible delivery format. Large reviews support benefit across anxiety and related conditions, including durable effects in many trials. The strongest models combine structured evidence-based content with appropriate human guidance, outcome monitoring and escalation when risk or complexity increases. [10]

Virtual-reality exposure

VR-assisted exposure is increasingly credible for phobias and social anxiety. A 2026 meta-analysis of 26 randomised trials involving 1,649 participants found meaningful reductions in anxiety and phobia symptoms, while noting the need for further standardisation and high-quality trials. VR is best understood as a delivery tool for exposure principles, not a separate cure. [14]

More precise psychotherapy

Research is increasingly examining which CBT components matter for which people—for example intolerance of uncertainty in GAD, self-focused attention and post-event processing in social anxiety, or interoceptive fear in panic disorder. Measurement-based care, routine symptom tracking and functional outcomes are becoming more important than a one-size-fits-all therapy label.

AI mental-health tools

AI-based coaching and conversational tools are expanding rapidly, but evidence quality, privacy, crisis management and clinical accountability vary. They may support psychoeducation, reflection or between-session practice; they should not be treated as a substitute for professional assessment when symptoms are severe, diagnosis is uncertain, medication is involved or there is risk.

Psychedelics and ketamine

Interest in psychedelic-assisted therapy and ketamine has expanded across psychiatry, but neither should currently be presented as standard treatment for primary anxiety disorders. Evidence is condition-specific, often early-stage, and access is tightly governed. People with anxiety should not be encouraged to self-medicate with unregulated psychedelic or dissociative substances.

13. Getting help in the UK

In England, adults can usually self-refer directly to NHS Talking Therapies for anxiety and depression without needing a formal diagnosis or a GP referral. Services provide NICE-recommended psychological treatments and may offer face-to-face, remote, individual or group formats depending on the condition and local service. [5]

Routine or persistent symptoms

Self-refer to NHS Talking Therapies in England, or speak to your GP—especially if symptoms are persistent, worsening, unclear, medically complicated or not responding to self-help.

Routine or persistent symptoms

Self-refer to NHS Talking Therapies in England, or speak to your GP—especially if symptoms are persistent, worsening, unclear, medically complicated or not responding to self-help.

Urgent mental-health help

In England, use NHS 111 online or call 111 and select the mental-health option for urgent support. NHS 111 mental-health access is available 24/7 and routes callers to local crisis services. [6]

Immediate danger

If there is immediate risk to life, severe injury or a medical emergency, call 999 or go to A&E.

Someone to talk to

Samaritans: 116 123, available day or night. See the Samaritans website for other contact options.

This guide is educational

It is designed to support understanding and informed discussion, not to diagnose an individual or replace personalised medical advice. Severe, rapidly changing, medically unusual or high-risk symptoms deserve direct clinical assessment.

14. References and trusted resources

The original Neurohaven page was reviewed and then rebuilt using current UK guidance and recent evidence available up to August 2026. Links below are provided so the page can be maintained as evidence evolves.

World Health Organization. Anxiety disorders. Updated 8 September 2025. Open source
NICE. Generalised anxiety disorder and panic disorder in adults: management (CG113). Current page includes April 2026 update information. Open source
NICE. Social anxiety disorder: recognition, assessment and treatment (CG159). Last reviewed May 2024. Open source
NHS. Anxiety, fear and panic. Page reviewed 13 July 2026. Open source
NHS England. NHS Talking Therapies for anxiety and depression. Open source
NHS. How to find local mental health services / urgent mental health support. Open source
Cuijpers P, et al. Cognitive Behavior Therapy for Mental Disorders in Adults: A Unified Series of Meta-Analyses. JAMA Psychiatry. 2025. PMID 40238104. Open source
Hofmann SG, Kasch C, Reis A. Effect sizes of randomized-controlled studies of cognitive behavioral therapy for anxiety disorders over the past 30 years. Clinical Psychology Review. 2025;117:102553. Open source
Dai X, et al. (Third-wave) cognitive behavioral therapy for generalized anxiety disorder in adults: systematic review and Bayesian network meta-analysis. Journal of Psychiatric Research. 2025;187:134–143. Open source
Updated umbrella and long-term evidence on internet-delivered CBT, including 154 RCTs with ≥12-month follow-up. Clinical Psychology Review. 2024/2025. PMID 39579466. Open source
Lei EFC, et al. Effectiveness and acceptability of exercise treatments for adults with anxiety disorders: systematic review and network meta-analysis. BMJ Open Sport & Exercise Medicine. 2026. PMID 41574022. Open source
Su H, et al. The effects of exercise on generalized anxiety symptoms in adults: systematic review and meta-analysis. BMC Sports Science, Medicine and Rehabilitation. 2026. PMID 42129849. Open source
Symptoms of Anxiety in Adults with ADHD: A Systematic Review and Meta-Analysis of Case-Control Studies. Journal of Attention Disorders. 2026. PMID 42400277. Open source
Chang YC, et al. Innovative virtual reality exposure therapy for anxiety and posttraumatic stress disorder: meta-analysis of randomised controlled trials. Journal of Global Health. 2026. PMID 41891221. Open source

Understanding anxiety disorders, panic and fear